These studies strongly indicate a link between AhR and energy expenditure in experimentally induced obesity, and open doors to the potential of targeting AhR as an effective treatment strategy for obesity and related comorbidities, including DM. This evidence concerns the gene AHR and obesity due to melanocortin 4 receptor deficiency.